• PDF / 169,435 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 102 Downloads / 183 Views

DOWNLOAD

REPORT

---

1 S

Pneumonitis: case report In a randomised, prospective, single‑institutional, consecutive cohort study of 60 patients with locally advanced unresectable non-small cell lung carcinoma (NSCLC) enrolled from December 2013 to December 2014, one patient [age and sex not stated] was described, who developed pneumonitis following neoadjuvant chemotherapy with cisplatin and paclitaxel for locally advanced unresectable NSCLC. The patient who had locally advanced unresectable NSCLC received 4 cycles of neoadjuvant chemotherapy consisting of cisplatin injection 75 mg/m2 divided into day 1 and day 2 and IV paclitaxel injection 175 mg/m2 on day 1, repeated every 3 weeks [not all routes stated]. Subsequently, the patient received radiation therapy. However, the patient developed treatment related grade III pneumonitis [time to reactions onsets and outcomes not stated]. Kumar R, et al. Neo-adjuvant chemotherapy followed by either continuous hyper-fractionated accelerated radiation therapy week-end less or conventional chemo-radiotherapy in locally advanced NSCLC-A randomised prospective single institute study. Journal of Cancer Research and Therapeutics 16: 860-866, No. 4, Sep 2020. Available from: 803519535 URL: http://doi.org/10.4103/jcrt.JCRT_377_16

0114-9954/20/1833-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 5 Dec 2020 No. 1833